International Flavors & Fragrances Return on Tangible Equity 2010-2023 | IFF
Current and historical return on tangible equity values for International Flavors & Fragrances (IFF) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| International Flavors & Fragrances Return On Tangible Equity Historical Data |
| Date |
TTM Net Income |
Tangible Equity |
Return on Tangible Equity |
| 2023-12-31 |
$-2.57B |
$-4.35B |
56.90% |
| 2023-09-30 |
$0.02B |
$-4.40B |
-0.39% |
| 2023-06-30 |
$-2.20B |
$-4.66B |
44.45% |
| 2023-03-31 |
$-2.12B |
$-4.64B |
40.80% |
| 2022-12-31 |
$-1.87B |
$-4.77B |
34.38% |
| 2022-09-30 |
$-1.76B |
$-5.77B |
30.81% |
| 2022-06-30 |
$0.64B |
$-5.65B |
-10.99% |
| 2022-03-31 |
$0.56B |
$-5.58B |
-9.13% |
| 2021-12-31 |
$0.27B |
$-5.80B |
-4.18% |
| 2021-09-30 |
$0.25B |
$-6.08B |
-4.48% |
| 2021-06-30 |
$0.14B |
$-6.90B |
-3.07% |
| 2021-03-31 |
$0.20B |
$-7.08B |
-6.01% |
| 2020-12-31 |
$0.36B |
$-2.00B |
-17.83% |
| 2020-09-30 |
$0.38B |
$-2.01B |
-18.39% |
| 2020-06-30 |
$0.42B |
$-2.03B |
-20.10% |
| 2020-03-31 |
$0.47B |
$-2.10B |
-21.88% |
| 2019-12-31 |
$0.46B |
$-2.12B |
-20.82% |
| 2019-09-30 |
$0.39B |
$-2.14B |
-17.09% |
| 2019-06-30 |
$0.35B |
$-2.24B |
-32.41% |
| 2019-03-31 |
$0.32B |
$-2.25B |
-66.32% |
| 2018-12-31 |
$0.34B |
$-2.37B |
249.17% |
| 2018-09-30 |
$0.28B |
$2.50B |
37.47% |
| 2018-06-30 |
$0.30B |
$0.22B |
166.25% |
| 2018-03-31 |
$0.31B |
$0.20B |
202.62% |
| 2017-12-31 |
$0.30B |
$0.12B |
222.56% |
| 2017-09-30 |
$0.42B |
$0.19B |
244.71% |
| 2017-06-30 |
$0.40B |
$0.11B |
163.81% |
| 2017-03-31 |
$0.40B |
$0.12B |
123.34% |
| 2016-12-31 |
$0.41B |
$0.27B |
103.57% |
| 2016-09-30 |
$0.41B |
$0.47B |
98.12% |
| 2016-06-30 |
$0.42B |
$0.45B |
110.79% |
| 2016-03-31 |
$0.41B |
$0.38B |
91.45% |
| 2015-12-31 |
$0.42B |
$0.35B |
75.01% |
| 2015-09-30 |
$0.43B |
$0.34B |
64.71% |
| 2015-06-30 |
$0.43B |
$0.72B |
53.73% |
| 2015-03-31 |
$0.44B |
$0.82B |
52.27% |
| 2014-12-31 |
$0.41B |
$0.77B |
50.66% |
| 2014-09-30 |
$0.39B |
$0.89B |
47.11% |
| 2014-06-30 |
$0.38B |
$0.85B |
48.32% |
| 2014-03-31 |
$0.37B |
$0.76B |
50.03% |
| 2013-12-31 |
$0.35B |
$0.77B |
50.46% |
| 2013-09-30 |
$0.36B |
$0.74B |
55.88% |
| 2013-06-30 |
$0.28B |
$0.68B |
46.52% |
| 2013-03-31 |
$0.26B |
$0.61B |
47.40% |
| 2012-12-31 |
$0.25B |
$0.55B |
48.11% |
| 2012-09-30 |
$0.21B |
$0.55B |
42.84% |
| 2012-06-30 |
$0.28B |
$0.52B |
58.01% |
| 2012-03-31 |
$0.26B |
$0.49B |
56.59% |
| 2011-12-31 |
$0.27B |
$0.40B |
60.63% |
| 2011-09-30 |
$0.30B |
$0.49B |
72.46% |
| 2011-06-30 |
$0.29B |
$0.48B |
84.26% |
| 2011-03-31 |
$0.28B |
$0.39B |
108.71% |
| 2010-12-31 |
$0.26B |
$0.29B |
140.24% |
| 2010-09-30 |
$0.26B |
$0.24B |
198.06% |
| 2010-06-30 |
$0.23B |
$0.13B |
287.85% |
| 2010-03-31 |
$0.21B |
$0.10B |
455.91% |
| 2009-12-31 |
$0.20B |
$0.05B |
9750.00% |
| Sector |
Industry |
Market Cap |
Revenue |
| Consumer Staples |
Consumer Products - Misc. Discretionary |
$21.603B |
$11.479B |
|
Flavors & Fragrances is a global leader in high-value ingredients and solutions for food and beverage, home and personal care, and health & wellness markets. It has 4 business units: Nourish, Scent, Health & Biosciences and Pharma Solutions; comprising 3 platforms: Ingredients, Flavors & Food Designs. Ingredients provide texturizing solutions to the food industry, food protection solutions for food and beverage products, specialty soy & pea protein with value-added formulations, emulsifiers and sweeteners. Flavors provide a range of flavor compounds & natural taste solutions, and value-added spices and seasoning ingredients. Food Designs offer savory solution products. Health & Biosciences includes, Health, Cultures & Food Enzymes, Home & Personal Care, Animal Nutrition, Grain Processing and Microbial Control, with a biotechnology-driven portfolio of products that serve the health and wellness, food, consumer and industrial markets. Pharma Solutions produces cellulosics and alginates-based pharma excipients.
|
